TIA Clinical Trials in Harbin, Heilongjiang
3 recruitingHarbin, Heilongjiang, China
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)
Potentially Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital398 enrolled2 locationsNCT06796803
Recruiting
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269
Recruiting
Phase 3
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）
TIAIschemic Stroke, Acutesymptomatic intracranial artery stenosis
Beijing Tiantan Hospital4,674 enrolled5 locationsNCT06319846